We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Absorbable Anchor for Fracture Fixation System

By HospiMedica staff writers
Posted on 10 Mar 2004
A new absorbable anchor for the TranSet fracture fixation system slowly degrades over time, eliminating the need for surgical removal. More...
The anchor has been cleared by the U.S. Food and Drug Administration (FDA).

TranSet is a fracture fixation system that employs suture and anchors to set bones and tissue. Anchors are applied to the outer bone cortex with suture running across the fracture, providing stabilization and linear fixation of the bone or tissue fragments. This compresses the bone or tissue fragments to promote healing. The TranSet fracture fixation system and the new anchor, called PLLA, will be displayed at the annual meeting of the American Academy of Orthopedic Surgeons in San Francisco (CA, USA).

The cylindrical design of the TranSet anchors also allows them to be used in orthopedic ligament and tendon repair and reconstruction. They distribute suture tension over larger repair areas and eliminate any suture tearing or pulling through the tissue. The anchor and the fixation system are the products of Bonutti Technologies (Effingham, IL, USA). The company was founded by Peter M. Bonutti M.D., a pioneer in minimally invasive knee replacement and balloon dissection technology.


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.